Literature DB >> 19340604

Polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of nasopharyngeal carcinoma in a Chinese population.

Tao Wang1, Kai Hu, Jinghua Ren, Qingyao Zhu, Gang Wu, Gang Peng.   

Abstract

Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF responsiveness and is implicated in various types of diseases with a putative angiogenic basis, but its role in nasopharyngeal carcinoma (NPC) is not fully understood. In this report, we sought to investigate whether the VEGF-2578C/A polymorphism was associated with NPC in a Chinese population. We carried out polymerase chain reaction-restriction fragment length polymorphism in blood genomic DNA of 156 NPC patients and 161 control subjects. The VEGF-2578A allele carriers were significantly associated with an increased risk of NPC (odds ratio: 1.648; 95% confidence interval: 1.053-2.580; P = 0.029). In contrast, NPC patients with the -2578CC genotype were shown higher tumor aggressiveness of large tumor size, poor differentiation and advanced stage as compared to the -2578A allele carriers. No correlation was observed between the genotype or allele distribution and lymph node metastasis or family history of cancer. The VEGF-2578C/A polymorphism was shown to be inconsistent with the onset and aggressiveness of NPC. The precise mechanisms of the polymorphism on the differing status in NPC should be elucidated in further studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340604     DOI: 10.1007/s11033-009-9526-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection.

Authors:  Majid Shahbazi; Anthony A Fryer; Vera Pravica; Iain J Brogan; Helen M Ramsay; Ian V Hutchinson; Paul N Harden
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.

Authors:  M D Mueller; J L Vigne; A Minchenko; D I Lebovic; D C Leitman; R N Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

3.  No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.

Authors:  Ilke H Onen; Ece Konac; Muzaffer Eroglu; Cagri Guneri; Hasan Biri; Abdullah Ekmekci
Journal:  Mol Biol Rep       Date:  2007-01-11       Impact factor: 2.316

4.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

5.  Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.

Authors:  Qianren Jin; Kari Hemminki; Kerstin Enquist; Per Lenner; Ewa Grzybowska; Rüdiger Klaes; Roger Henriksson; Bowang Chen; Jolanta Pamula; Wioletta Pekala; Helena Zientek; Jadwiga Rogozinska-Szczepka; Beata Utracka-Hutka; Göran Hallmans; Asta Försti
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

6.  Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.

Authors:  Yoshihisa Kawai; Shigeru Sakano; Yoshihito Korenaga; Satoshi Eguchi; Katsusuke Naito
Journal:  Eur Urol       Date:  2007-01-30       Impact factor: 20.096

7.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

8.  Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4.

Authors:  Bing-Jian Feng; Wei Huang; Yin Yao Shugart; Ming K Lee; Feng Zhang; Jian-Chuan Xia; Hui-Yun Wang; Teng-Bo Huang; Shao-Wen Jian; Ping Huang; Qi-Sheng Feng; Li-Xi Huang; Xing-Juan Yu; Duang Li; Li-Zheng Chen; Wei-Hua Jia; Yan Fang; Hui-Ming Huang; Jing-Liu Zhu; Xiao-Ming Liu; Yan Zhao; Wang-Qing Liu; Mang-Quan Deng; Wei-Han Hu; Shao-Xiong Wu; Hao-Yuan Mo; Ming-Fang Hong; Mary Claire King; Zhu Chen; Yi-Xin Zeng
Journal:  Nat Genet       Date:  2002-07-15       Impact factor: 38.330

9.  Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells.

Authors:  B Williams; A Q Baker; B Gallacher; D Lodwick
Journal:  Hypertension       Date:  1995-05       Impact factor: 10.190

10.  Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.

Authors:  Eric J Jacobs; Heather Spencer Feigelson; Elizabeth B Bain; Kerri A Brady; Carmen Rodriguez; Victoria L Stevens; Alpa V Patel; Michael J Thun; Eugenia E Calle
Journal:  Breast Cancer Res       Date:  2006-04-13       Impact factor: 6.466

View more
  9 in total

Review 1.  Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Authors:  Allan Hildesheim; Cheng-Ping Wang
Journal:  Semin Cancer Biol       Date:  2012-01-25       Impact factor: 15.707

2.  Association between VEGF -634G/C polymorphism and osteonecrosis of the femoral head susceptibility: a meta analysis.

Authors:  Yaosheng Liu; Zhicheng Zhang; Shubin Liu; Xiuyun Su; Shiguo Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk.

Authors:  Praveen Kumar Jaiswal; Nidhi Tripathi; Alka Shukla; Rama Devi Mittal
Journal:  Med Oncol       Date:  2013-02-21       Impact factor: 3.064

4.  Butyrate increases the formation of anti-angiogenic vascular endothelial growth factor variants in human lung microvascular endothelial cells.

Authors:  J Ciura; P P Jagodziński
Journal:  Mol Biol Rep       Date:  2010-03-07       Impact factor: 2.316

5.  Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case-control study.

Authors:  Xianglei Wu; Dongqing Li; Zhisu Liu; Xinyue Wan; Yunhua Wu; Congqin Jiang; Qun Qian
Journal:  Mol Biol Rep       Date:  2010-09-21       Impact factor: 2.316

6.  Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians.

Authors:  Ruhi Kapahi; Kamlesh Guleria; Vasudha Sambyal; Mridu Manjari; Meena Sudan; Manjit Singh Uppal; Neeti Rajan Singh
Journal:  Tumour Biol       Date:  2015-01-22

7.  Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects.

Authors:  Chao Cao; Tao Ying; Jing-Jing Fang; Shi-Fang Sun; Dan Lv; Zhong-Bo Chen; Hong-Ying Ma; Yi-Ming Yu; Qun-Li Ding; Li-Hua Shu; Zai-Chun Deng
Journal:  Med Oncol       Date:  2010-07-16       Impact factor: 3.064

8.  Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

Authors:  Junyin Tan; Li Jiang; Xiaowei Cheng; Chunlin Wang; Jingshan Chen; Xiaoqing Huang; Peng Xie; Dongmei Xia; Rensheng Wang; Yong Zhang
Journal:  Onco Targets Ther       Date:  2017-02-15       Impact factor: 4.147

9.  No associations of a set of SNPs in the Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase (MMP) genes with survival of colorectal cancer patients.

Authors:  Lydia A Dan; Salem Werdyani; Jingxiong Xu; Konstantin Shestopaloff; Angela Hyde; Elizabeth Dicks; Ban Younghusband; Jane Green; Patrick Parfrey; Wei Xu; Sevtap Savas
Journal:  Cancer Med       Date:  2016-06-23       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.